Several potential adverse effects of TYK2 inhibitors, including headache, upper respiratory tract infection, nausea, diarrheal, increased circulating levels of creatinine and liver enzymes, and risk of certain malignant neoplasms, such prostate and breast cancer, should be further explored. This evidence concerns the gene TYK2 and breast cancer.